EPMA Journal is a journal of predictive, preventive and personalized medicine (PPPM). The journal provides expert viewpoints and research on medical innovations and advanced healthcare using predictive diagnostics, targeted preventive measures and personalized patient treatments. The journal is indexed by PubMed, Embase and Scopus.

  • The only journal in the field of predictive, preventive and personalized medicine (PPPM)
  • High visibility for your research
  • Official journal of the European Association for Predictive, Preventive & Personalised Medicine

Journal information

Editor-in-Chief
  • Olga Golubnitschaja
Publishing model
Hybrid (Transformative Journal). Learn about publishing Open Access with us

Journal metrics

4.901 (2019)
Impact factor
21 days
Submission to first decision
89 days
Submission to acceptance
124,537 (2019)
Downloads

Latest issue

Volume 11

Issue 4, December 2020

PPPM Relevant Tools and Approaches in Combating COVID-19 Pandemic, Diseases' Development and Progression

Latest articles

Journal updates

  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

  • Featured article: Challenging management of severe chronic disorders in acute pandemic situation

    Chronic liver disease management is a comprehensive approach requiring multi-professional expertise and well-orchestrated healthcare measures thoroughly organized by responsible medical units. The corresponding multi-faceted chain of healthcare events is likely to be severely disturbed or even temporarily broken under the force majeure conditions such as global pandemics. Consequently, the chronic liver disease is highly representative for the management of any severe chronic disorder under lasting pandemics with unprecedented numbers of acutely diseased persons who, together with the chronically sick patient cohorts, have to be treated using the given capacity of healthcare systems with their limited resources.


    In this study, researchers explored the potential negative impact of the SARS CoV-2 outbreak on the quality of the advanced chronic liver disease (ACLD) management by considering two well-classified parameters: (1) the continuity of the patient registrations and (2) the level of mortality rates, comparing pre-COVID-19 statistics with these under the current pandemic in Slovak Republic.

    New Content Item
View all updates

About this journal

Electronic ISSN
1878-5085
Print ISSN
1878-5077
Abstracted and indexed in
  1. ANVUR
  2. CAB Abstracts
  3. CNKI
  4. Dimensions
  5. EBSCO Discovery Service
  6. EMBASE
  7. Gale
  8. Google Scholar
  9. Institute of Scientific and Technical Information of China
  10. Japanese Science and Technology Agency (JST)
  11. Journal Citation Reports/Science Edition
  12. Meta
  13. Naver
  14. OCLC WorldCat Discovery Service
  15. ProQuest Central
  16. ProQuest Health & Medical Collection
  17. ProQuest Health Research Premium Collection
  18. ProQuest-ExLibris Primo
  19. ProQuest-ExLibris Summon
  20. Psyndex
  21. PubMedCentral
  22. Reaxys
  23. SCImago
  24. SCOPUS
  25. Science Citation Index Expanded (SciSearch)
  26. TD Net Discovery Service
  27. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© European Association for Predictive, Preventive and Personalised Medicine (EPMA)